Skip to main content

Interpreting Binding Data

Interpreting Peptide Binding Data

A binding experiment returns numbers whether or not the underlying interaction is real. This page explains what the common parameters mean, which artifacts produce convincing but misleading data, and what a careful reader or reviewer will expect to see reported.

The basic parameters

ParameterUnitsWhat it describes
KD, equilibrium dissociation constant Molar (M) The concentration at which half the binding sites are occupied at equilibrium. Smaller means tighter.
ka or kon, association rate M−1s−1 How quickly the complex forms once the partners meet.
kd or koff, dissociation rate s−1 How quickly the complex falls apart.
Residence time Seconds 1 / kd. The average lifetime of the complex once formed.
IC50 Molar (M) Competitor concentration that halves the signal. Depends on the assay conditions, so it is not an intrinsic constant.
Stoichiometry (n) Dimensionless Binding sites per molecule. Available from ITC and a valuable sanity check.

KD is related to the rates by KD = kd / ka. Two peptides can share a KD and behave very differently: one binding and releasing quickly, the other binding slowly and staying bound. For inhibitor work the residence time often predicts cellular behaviour better than affinity alone, which is why kinetic methods are worth the extra effort when the goal is a functional molecule.

Is the concentration right?

Every affinity number inherits the accuracy of the concentrations used to calculate it. This is the most common invisible error in peptide work, and it is worth stating plainly: a KD is only as good as the peptide concentration behind it.

Lyophilized peptide is not pure peptide by weight. It contains bound water and counter-ions, and the fraction that is actually peptide — the net peptide content — varies with sequence and purification history. Dissolving "1 mg" of powder in 1 mL does not give a 1 mg/mL peptide solution. If the true content is 70 %, every affinity constant derived from that stock is out by the same factor.

For quantitative work, determine concentration by absorbance at 280 nm if the peptide contains tryptophan or tyrosine, or by amino acid analysis if it does not. See calculating peptide concentration and net peptide content.

Artifacts that look like binding

Avidity reported as affinity

If either partner is multivalent — an antibody with two arms, a dimeric protein, or a densely coated surface presenting many copies of the peptide — the measured affinity will be tighter than the true single-site value, and dissociation will look unrealistically slow. The diagnostic is surface density: prepare several densities and check whether the fitted KD changes. If it does, you are measuring avidity.

Aggregation

Aggregating peptides produce steep, cooperative-looking curves, apparent stoichiometries that make no structural sense, and poor reproducibility between preparations. A Hill slope substantially above one in a system with no reason for cooperativity is a warning sign. So is a result that shifts when the stock is diluted differently or after a freeze-thaw cycle. Dynamic light scattering or a simple centrifugation step before the measurement will often settle the question.

Non-specific electrostatic binding

Highly cationic peptides, including many cell-penetrating sequences, bind negatively charged surfaces, dextran matrices and plasticware. The resulting signal can be dose-dependent and perfectly reproducible without reflecting a specific interaction. Raising the salt concentration moderately, using a reference surface and testing a scrambled peptide of identical charge all help to distinguish the two.

Bulk refractive index and buffer mismatch

In surface methods, a sample buffer different from the running buffer produces a square-shaped jump at injection and again at the end. In calorimetry, mismatched buffers produce heats that have nothing to do with binding. DMSO is the usual culprit in both cases: it must be matched closely across all samples, including the controls.

Depletion at low concentrations

When the target concentration is comparable to or above the KD, free ligand is measurably depleted by binding, and the simple fitting equation no longer applies. The fitted KD then collapses towards the target concentration regardless of the true affinity. Working below the expected KD, or using a fitting model that accounts for depletion, avoids reporting a number that is really just your target concentration.

Sanity checks before you believe a result

  • Does the scrambled control show no binding, and the point mutant show reduced binding?
  • Does the measured affinity stay the same when surface density, tracer concentration or immobilization chemistry is changed?
  • Is the Hill slope close to one, or is there a structural reason it should not be?
  • Does the stoichiometry, where available, match the expected number of sites?
  • Does a second, mechanistically different method give a comparable answer?
  • Do independent peptide batches and independent protein preparations agree?

Weak binding is a result

A peptide that binds at high micromolar affinity has not failed. Isolated linear motifs frequently bind in that range, and such interactions are biologically important when they occur at high local concentration or in multivalent arrays. The honest course is to report the number with its uncertainty and the method used, rather than to search for conditions that produce a more attractive one.

What to report

Reviewers increasingly expect the detail that makes a measurement reproducible. A complete report usually includes:

  • The exact peptide sequence, including terminal modifications, tags and spacers.
  • Purity, and how concentration was determined.
  • Buffer composition, pH, temperature and any DMSO content.
  • Method, instrument, immobilization or labeling chemistry, and surface density where relevant.
  • The fitting model used, and the fitted parameters with uncertainties.
  • Number of independent replicates, and whether they used separate peptide preparations.
  • Control data, not only a statement that controls were performed.

Keeping the certificate of analysis for each peptide batch alongside the data makes this straightforward to assemble later, and answers most questions a reviewer is likely to raise about the material itself.

Analyze your sequence

Paste a peptide or protein sequence to review length, charge, hydrophobicity and other properties before you order.

Related pages

Research use only. LifeTein peptides and proteins are supplied for laboratory research use. They are not for human or veterinary use, and not for diagnostic or therapeutic use. See our research use policy.

Quotation

If you need peptides with accurately determined content for quantitative binding work, or a binding measurement performed for you, email sales@lifetein.com or use our quotation form.